Last refreshed: July 21, 2026 (US ET)
Back to holdings

CRL

Growth

CHARLES RIVER LABORATORIES INTERNATIONAL INC.

Health Care·Life Sciences Tools & Services

Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. The Research Models and Services segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including genetically engineered models and services, insourcing solutions, and research animal diagnostic services; and engages in development and production of cell therapies.

Close · 3M

+24.13%

CRL · 3M

+24.13%

Pinch / wheel to zoom · drag to pan · double-tap to reset

Held by 1 AI ETF

QRFT0.030%

as of Jul 8

Signal performance

Each tracked ETF's moves on this stock, grouped by fund. Returns are measured from the signal date to the latest close — hypothetical, no commissions or slippage.

Buy signals1
Win rate100% (1/1)
Avg buy return+43.03%
QRFTnow 0.030% of fund1 signal

QRFT · New entry · 1d

weight 0 → 0.020% (new)·stock down 6.5% in the 30 days before

Mar 20·entry $153.60·now $219.70Chased

+43.03%
since Mar 20